Final Results from Quasar2, a Multicentre, International Randomised Phase III Trial of Capecitabine (Cap) +/- Bevacizumab (Bev) in the Adjuvant Setting of Stage Ii/Iii Colorectal Cancer (Crc)

Annals of Oncology - Tập 25 - Trang v1 - 2014
R.S. Midgley1, S. Love1, I. Tomlinson2, E. Johnstone1, C. Scudder1, S.R. Pearson1, P. Julier1, E. Domingo2, D. Church1, F. Pezzella3, J. Hu3, E. Segelov4, A. Weaver5, D.J. Kerr3
1Department of Oncology, University of Oxford, Oxford, UK
2Department of Clinical Medicine, University of Oxford, Oxford, UK
3Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford, UK
4St Vincents Clinical School, University of New South Wales, Sydney, NSW, Australia
5Department of Oncology, Oxford University Hospitals Trust, Oxford, UK

Thông tin
Thông tin xuất bản

Annals of Oncology

Tập 25

v1

Thông tin tác giả